The termination of neurotransmission is achieved by rapid uptake of th
e released neurotransmitter by specific high-affinity neurotransmitter
transporters. Most of these transporters are encoded by a family of g
enes (Na+/Cl- transporters) having a similar membrane topography of 12
transmembrane helices. An evolutionary tree revealed five distinct su
bfamilies: gamma-aminobutyric acid transporters, monoamine transporter
s, amino acid transporters, ''orphan'' transporters, and the recently
discovered bacterial transporters. The bacterial transporters that bel
ong to this family may help to develop heterologous expression systems
with the aim of solving the three-dimensional structure of these memb
rane proteins. Some of the neurotransmitter transporters have been imp
licated as important sites for drug action. Monoamine transporters, fo
r example, are targeted by major classes of antidepressants, psychosti
mulants, and antihypertensive drugs. Localization of individual transp
orters in specific cells and brain areas is pertinent to understanding
their contribution to neurotransmission and their potential as target
s for drugs. The most important questions in the field include resolvi
ng the mechanism of neurotransmitter transport, the structure of the t
ransporters, and the interaction of each transporter in complex neurol
ogical activities.